State of U.S.'s AT CDMO Sector

The inaugural issue of Project Evolution’s State of the U.S. AT CDMO Sector delved into the recent surge in layoffs within the Biomanufacturing CDMO markets which includes Advanced Therapies and biologic CDMOs. In that post, we discussed the factors we believe have contributed to this slowdown. Now,

This post marks the commencement of a series delving into the landscape of the U.S. Advanced Therapies (AT) Contract Development Manufacturing Organizations (CDMOs) sector. Before delving into the report's core content, which includes an exploration of the country's prominent biomanufacturing hubs,